Carlyle Group sells 1.24pc stake in Metropolis Healthcare for Rs 84 crore, makes complete exit
Mumbai: Private Equity firm The Carlyle Group arm, CA Lotus Investments made a complete exit from diagnostics chain Metropolis Healthcare by divesting 1.24 percent residual equity stake for Rs 84.23 crore via open market transactions.
In 2015, a unit of Carlyle Group LP had bought a stake in Metropolis Healthcare Ltd, the India-based global operator of pathology laboratories, for an undisclosed sum, according to a statement from the U.S. private equity firm. An affiliate of buyout fund Carlyle Asia Partners IV had bought the stake in Metropolis from former promoter Dr GSK Velu and his affiliates.
Also Read: Metropolis Labs Sells Out A Stake To Carlyle Group Unit
On Friday, the PE firm sold 6.28 lakh shares at a price of Rs1,341 per share, held by its entity called CA Lotus Investments. Metropolis shares closed trading at 1,358.1 per share, up 0.27% on the BSE.
CA Lotus Investments sold shares of Metropolis in two tranches of 3,14,106 and 3,14,017 shares at Rs 1,341 each. The shares were bought by several institutional investors such as ICICI Prudential MF, Aditya Birla Sun Life MF, and Sundaram BNP Paribas MF.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.